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impairs insulin signaling in endothelial cells
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Abstract 
Background: Hyperglycemia is the hallmark of diabetes and its cardiovascular complications. Insulin plays an 
important role in the regulation of vascular homeostasis and maintenance of endothelial function. Insulin signaling 
occurs after binding to the insulin receptor, causing activation of two separate and parallel pathways: PI3K/AKT/eNOS 
and Ras/Raf/MAPK pathways. AKT phosphorylates eNOS at Ser1177, resulting in increased nitric oxide production and 
vasodilation. The MAPK pathway results in endothelin-1 production and vasoconstriction and mitogenic effects.
Methods: We studied the effects of physiological insulin treatment in human umbilical vein endothelial cells 
(HUVECs) on the two pathways under high glucose conditions, which mimic the in vivo condition of hyperglycemia. 
HUVECs were incubated with insulin at different physiological concentrations (from 10−10 to 10−8 M) for 30 min after 
24 h of exposition to normal (5 mmol/L, NG) or high glucose (25 mmol/L, HG). Phosphorylated forms of AKT, eNOS, 
ERK1/2, p38, JNK and insulin receptor-β subunit (IRβ) were evaluated.
Results: In normal glucose, the active phosphorylated forms of AKT, eNOS, ERK1/2, p38 and JNK were increased in 
insulin treated cells, in a dose-dependent manner. In high glucose, insulin was not able to activate the PI3K/AKT/
eNOS pathway, with the phosphorylated form of eNOS reduced with respect to the control. However, insulin was able 
to induce the up-regulation of phospho-ERK1/2, -p38 and -JNK. Moreover, we found reduced levels of IRβ phospho-
rylated form in high glucose as compared to the control. Insulin was able to increase phospho-IRβ in normal glucose 
but not in high glucose, in which the total protein levels remained reduced.
Conclusions: Exposure to short-term high glucose negatively affects insulin signaling even when physiological insu-
lin concentrations are added. The impairment of the PI3K/AKT/eNOS pathway after physiological insulin treatment 
could contribute to detrimental effects on cardiovascular homeostasis under high glucose conditions, and might 
shift toward the activation of certain mitogenic effectors, such as ERK1/2, p38 and JNK, the only ones that respond to 
physiological insulin treatment in high glucose.
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Background
The pathogenesis of cardiovascular complications in 
diabetes has been largely described and begins with 
endothelial dysfunction [1]. The endothelium plays a 
crucial role in maintaining cardiovascular homeostasis 
under physiological conditions by releasing a number of 
vasoactive substances, vasodilators and vasoconstrictors, 
in balance. They act together to regulate vascular tone, 
antiproliferation and antiaggregation, and, in addition, to 
limit increases in blood pressure, to control tissue blood 
flow and inflammatory responses [2, 3]. The endothe-
lium releases these vasoactive substances in response to 
mechanical stimuli, such as pressure and shear stress, as 
well as various hormonal stimuli, such as insulin.
Normal insulin signaling results in glucose uptake by 
skeletal muscle and fat, suppression of hepatic gluco-
neogenesis and vasodilation for increased eNOS enzy-
matic activity in the endothelium [4]. These effects are 
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mediated by insulin binding to the insulin receptor (IR), 
a ligand-activated tyrosine kinase receptor. Binding and 
activation of IR results in tyrosine phosphorylation of 
insulin receptor substrates (IRS) and Shc, leading to the 
activation of two parallel pathways: the PI3K/AKT/eNOS 
pathway, also known as the “metabolic arm”, and the Ras/
Raf/MAPK pathway, or the “mitogenic/pro-atherogenic 
arm”. Phosphorylation of IRS-1 leads to the activation 
of the PI3K/AKT/eNOS pathway. AKT kinase phos-
phorylates eNOS at Ser1177 and activates it, leading to 
the production of nitric oxide (NO). On the other hand, 
phosphorylation of Shc leads to activation of the Ras/Raf/
MAPK pathway, resulting in increased endothelin-1 (ET-
1) expression and mitogenic effects [5, 6].
Insulin resistance is an important feature of diabetes, 
obesity, glucose intolerance and dyslipidemia, and it is 
also a prominent component of cardiovascular disorders, 
including hypertension, coronary artery disease, and ath-
erosclerosis [7]. In the endothelium, a selective resistance 
to insulin is observed in the pathological state of hyper-
insulinemia [8, 9], when the PI3K/AKT/eNOS pathway 
is altered, resulting in diminished eNOS activity, reduced 
NO generation and diminished insulin-mediated vaso-
dilation; by contrast, the Ras/Raf/MAPK pathway is 
generally preserved, thus ET-1 production and mito-
genic effects persist contributing to the vascular effects 
of insulin resistance [10]. Several studies have investi-
gated the consequences of high insulin levels in vitro and 
in  vivo. In vitro, in human coronary artery endothelial 
cells (HCAECs) cultured in the presence of 20  mmol/L 
glucose and treated with an insulin concentration of 
50 nmol/L for 10 min, a reduction in insulin-stimulated 
phosphorylation of eNOS at Ser1177 was observed [11]. 
In vivo, Kubota et al. [12] demonstrated that the expres-
sion levels of insulin-stimulated phosphorylations of 
AKT and eNOS were decreased by 70–80 % in endothe-
lial cells extracted from the abdominal aorta of 8-week 
high-fat diet-fed mice and ob/ob mice, treated with an 
insulin concentration of 100 nmol/L for 30 min, indicat-
ing that insulin signaling was impaired in the endothelial 
cells of these obesity models. While several reports have 
investigated the role of hyperinsulinemia in the endothe-
lium [11–13] and in the liver [14] and muscle [14, 15], 
studies in which insulin is used at physiological concen-
trations are lacking.
The present study aimed to investigate the role of insu-
lin at physiological levels on vascular endothelium in the 
presence of high glucose concentrations. We hypoth-
esized that the impairment of the insulin signaling may 
occur in endothelial cells exposed to high glucose, not 
only at high insulin levels but also at physiological insu-
lin concentrations. In this way, we could help clarify the 




d-Glucose and insulin were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
Cell culture
HUVECs were purchased from Lonza and cultured in 
an endothelial cell growth medium-2 (EBM-2) (Lonza 
Bioresearch LBS, Basel, Switzerland) supplemented with 
hEGF, FBS, hFGF, heparin, hydrocortisone and GA-1000. 
It contained less than 10−12 M insulin, which was consid-
ered to have no effect on our outcome [16]. Cells were 
harvested at subconfluence and seeded into six-well 
plates.
Experimental design
The effects of various concentrations of insulin were 
examined in HUVECs cultured under normal glu-
cose (5  mmol/L, NG) and high glucose conditions 
(25 mmol/L, HG) for 24 h. In the last 30 min, HUVECs 
were treated with increasing physiological concentrations 
of insulin: 10−10 M = 100 pmol/L, 10−9 M = 10 nmol/L 
and 10−8 M  =  1  nmol/L. After insulin treatment, cells 
were collected for protein extraction and Western Blot 
analysis.
Protein extraction
Cells were harvested and whole cell lysates were prepared 
using a RIPA buffer (Sigma-Aldrich, St. Louis, MO, USA) 
with the addition of a protease and phosphatase inhibitor 
cocktail. Protein content of the lysates was determined 
using the Bradford reagent (Sigma-Aldrich, St. Louis, 
MO, USA).
Western blot analysis
Protein lysates (25 ug) were resolved by SDS–polyacryla-
mide gel electrophoresis (PAGE-R Gold gels 4–20  %, 
purchased from Lonza) and transferred to a polyvi-
nylidene fluoride (PVDF) membrane. After blocking 
with 5 % non-fat dry milk (NFDM) in 20 mM Tris–HCl 
(pH 7.5), 135 mM NaCl and 0.1 % Tween-20, blots were 
incubated with monoclonal antibodies against human 
phospho-AKT (Ser473), phospho-eNOS (Ser1177), 
phospho-ERK1/2 (Thr202/Tyr204), phospho-p38 
(Thr180/Tyr182), phospho-JNK (Thr183/Tyr185), AKT, 
eNOS, ERK1/2, p38 and JNK (Cell Signaling Technol-
ogy, Beverly, MA, USA), IRβ (Santa Cruz Biotechnol-
ogy, CA, USA) and phosphotyrosine (phospho-Tyr) 
(UBI, Upstate, Lake Placid, NY, USA) (1:1000). Human 
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β-actin (1:1000) (Sigma-Aldrich, St. Louis, MO, USA) 
was used as a loaded control. Detection was performed 
using a secondary peroxidase-linked anti-mouse/rabbit 
antibody (1:3000) (GE Healthcare Europe GmbH, Barce-
lona, Spain) and an enhanced chemiluminescence system 
(Pierce Chemical Co, Rockford, IL, USA) according to 
the manufacturer’s instructions. Proteins were revealed 
in a CCD camera (ImageQuantLAS4000, GE Healthcare, 
UK). Protein content quantification was performed using 
computer-assisted densitometry (http://www.imagej.nih.
gov, ImageJ Software, NIH).
Results
Acute high glucose enhanced AKT phosphorylation 
and attenuated eNOS phosphorylation in HUVECs
PI3K/AKT/eNOS is one of the two parallel pathways 
activated buy insulin after binding to its receptor [5]. Par-
ticularly, AKT is an important signaling molecule that is 
involved in different endothelial functions, for example 
the regulation of angiogenesis, proliferation, vascular 
permeability, survival and cellular transformation as well 
[17]. Also AKT may phosphorylate eNOS to promote 
vasodilation with increased NO production in endothe-
lial cells [5].
It has been shown that impaired PI3K/AKT signaling 
due to hyperglycemia may promote endothelial dysfunc-
tion in diabetes [18]. To this aim, we firstly investigated 
the effects of acute HG in AKT phosphorylation and in 
its effector eNOS in HUVECs. In high glucose, phos-
phorylation levels of Ser473AKT increased, while phos-
phorylation levels of Ser1177eNOS reduced versus the 
control. The total amount of AKT and eNOS protein 
levels remained unchanged (Fig. 1). These results suggest 
that acute HG impairs AKT/eNOS signal transduction.
Time course of insulin‑mediated eNOS phosphorylation 
at Ser1177 in HUVECs
In order to establish the optimal amount of time for 
insulin incubation, confluent HUVECs were treated 
with 100  pmol/L insulin at three different time points: 
5, 10 and 30  min. The insulin concentration used was 
100 pmol/L insulin because it corresponds to physiologi-
cal plasma insulin levels in humans, so this amount may 
be considered a good in  vitro representation of in  vivo 
insulin activity [16]. After insulin treatment, cells were 
collected and eNOS phosphorylation in Ser1177 levels 
were analyzed by Western Blot. We observed gradually 
increasing levels of Ser1177eNOS between 5 and 30 min, 
reaching statistical significance at 30 min (Fig. 2).
Physiological insulin administration enhanced 
AKT and eNOS phosphorylation in NG in a 
concentration‑dependent manner, but had no effects 
in HG in HUVECs
To investigate the alterations on the PI3K/AKT/
eNOS-dependent insulin signaling pathway under HG 
Fig. 1 Administration of high glucose for 24 h enhanced phosphor-Ser473AKT and attenuated phospho-Ser1177eNOS in HUVECs. Whole cell 
lysates were prepared from confluent HUVECs exposed to 5 mmol/L (NG) or 25 mmol/L (HG) glucose for 24 h. AKT and eNOS phosphorylations 
were assayed for Western Blot analysis. The panels show representative images of different independent experiments. Densitometric values were 
normalized to total amounts of AKT and eNOS, respectively. *P < 0.05, **P < 0.01 HG vs. NG. Bars represent mean ± SEM for five independent experi-
ments
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conditions, activation of AKT and eNOS was deter-
mined by immunoblotting. Insulin administered at dif-
ferent physiological concentrations under NG conditions 
caused a concentration-dependent increase in phospho-
Ser473AKT, which was statistically significant at the con-
centration of 10−9 and 10−8 M (Fig. 3). Contrary to what 
happened under NG, insulin physiological treatment 
under HG conditions did not cause the same effect.
To determine whether such a difference in endothelial 
AKT activity in response to insulin concentrations under 
the two conditions of NG and HG also had downstream 
consequences, we next evaluated the phosphorylation 
of eNOS. The different physiological insulin concen-
trations added at NG induced an increase in phospho-
Ser1177eNOS that nicely correlated to a dose between 
10−10 and 10−9 M, but was attenuated at 10−8 M. This 
could indicate a desensitization of the metabolic insulin 
signaling pathway. However, as the same insulin concen-
tration continued to increase phosphorylated AKT levels, 
this indicated that insulin preserved some ability to signal 
to the metabolic arm.
Interestingly, physiological insulin added to HUVECs 
acutely treated under high glucose conditions did not 
follow the same eNOS phosphorylation profile that we 
observed in NG, indicating that insulin could not prevent 
high glucose-dependent inhibition of eNOS activation.
Acute high glucose had no effects on ERK1/2, JNK and p38 
phosphorylation levels in HUVECs, and physiological 
insulin treatment increased them under NG and HG 
conditions
To investigate the alterations in the Ras/Raf/MAPK-
dependent insulin signaling pathway in HG, activation of 
ERK1/2, p38 and JNK was determined. In NG, HUVECs 
Fig. 2 Insulin 100 pmol/L slightly increased phospho-Ser1177eNOS 
at 5 and 10 min, with its major effect occurring at 30 min. HUVECs 
were treated with 100 pmol/L insulin at different time points: 5, 10 
and 30 min. Whole cell lysates were prepared for Western Blot analy-
sis. The panels show representative images of different independent 
experiments. Densitometric values were normalized to total eNOS. 
Bars represent mean ± SEM for five independent experiments. 
*P < 0.05 NG with insulin 100 pmol/L vs. NG w/o insulin treatment
Fig. 3 Insulin administration enhanced AKT and eNOS phosphorylation in NG in a concentration-dependent manner, but had no effects in HG 
in HUVECs. Confluent HUVECs were exposed to 5 mmol/L (NG) or 25 mmol/L (HG) glucose for 24 h. During the last 30 min HUVECs were treated 
with different physiological concentrations of insulin: 10−10 M = 100 pmol/L, 10−9 M = 10 nmol/L and 10−8 M = 1 nmol/L. Whole cell lysates were 
prepared for immunoblot analysis of AKT and eNOS phosphorylation. The panels show representative images of different independent experiments. 
Densitometric values were normalized to total amounts of AKT and eNOS, respectively. Bars represent mean ± SEM for five independent experi-
ments. *P < 0.05, **P < 0.01 HG vs. NG
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responded to insulin stimulation with an increase in 
ERK1/2 phosphorylation in a concentration-dependent 
manner, being statistically significant for insulin doses 
10−9 and 10−8 M. We obtained the same results for 
phospho-p38, which was statistically significant at insu-
lin doses of 10−8 M, and phospho-JNK, with a significant 
increase at the insulin concentrations of 10−9 and 10−8 M 
(p  <  0.05). Conversely to AKT and eNOS phosphoryla-
tion, 24 h of HG treatment did not affect the phosphoryl-
ated forms of ERK1/2, p38 or JNK. Intriguingly, insulin 
physiological treatment in HG maintained an increase of 
these forms in a concentration-dependent manner, and 
this increase was significant (1) at all insulin doses tested 
for phospho-ERK1/2, (2) at the concentration of 10−8 M 
for phospho-p38 and (3) at the concentrations of 10−9 
and 10−8 M for phospho-JNK (Fig. 4).
Acute high glucose attenuated IRβ expression in HUVECs. 
Insulin administration had no effects under NG and HG 
in terms of total amount but increased its phosphorylated 
form
We hypothesized that exposure of HUVECs to HG could 
affect the early steps of insulin signaling. To test this, IRβ 
protein expression levels were examined. Acute exposure 
of HUVECs to HG induced a significant decrease in IRβ 
tyrosine phosphorylation accompanied by a reduction in 
IRβ total protein versus the control (Fig. 5).
Insulin treatment under NG conditions enhanced in a 
dose-dependent manner IRβ tyrosine phosphorylation at 
all tested physiological insulin concentrations, but it had 
no effects under HG in HUVECs, although a statistically 
insignificant increase was observed. Insulin stimulation 
in NG had no effects on IRβ total expression compared 
with the untreated control. The decrease in IRβ total 
expression observed under HG conditions was not coun-
teracted by any tested dose of insulin (Fig. 5).
Discussion
In the present study, we show how HUVECs exposed to 
24  h of high glucose lose the capacity to respond nor-
mally at physiological insulin concentrations. This phe-
nomenon is only observed in the PI3K/AKT/eNOS 
pathway, while under the same conditions the Ras/Raf/
MAPK pathway responds to insulin treatment with the 
up-regulation of phosphorylated forms of ERK1/2, p38 
and JNK. This is consistent with the hypothesis that 
an imbalance occurs in the endothelial insulin signal-
ing between pro- and anti-atherogenic arms with insu-
lin preserving its ability to signal through the mitogenic 
arm, previously shown not to be affected under condi-
tions of high insulin levels [19–21]. In a novel manner, 
we show that stimulation of endothelial insulin signaling 
with physiological insulin concentrations in HUVECs 
pre-exposed to 24 h high glucose: (1) on the one hand, is 
not sufficient to activate the PI3K/AKT/eNOS pathway, 
as has occurred in other studies involving lower insulin 
dose incubations [11, 22]; (2) and on the other, it does 
not affect the MAPK-mediated insulin pathway, which 
not only is maintained but also is exacerbated, and this 
occurs at very low insulin concentrations.
An altered PI3K/AKT/eNOS pathway is a common 
feature observed in cellular models exhibiting impaired 
endothelial function [5]. eNOS phosphorylation at 
Ser1177 is necessary for its maximal activation and, 
consequently, for optimal NO production [23]. In the 
present study, we show that in HUVECs expression of 
Fig. 4 Administration of high glucose for 24 h had no effects on ERK1/2, p38 and JNK phosphorylations in HUVECs; however, insulin administration 
increased them under NG and HG conditions. Confluent HUVECs were exposed to 5 mmol/L (NG) or 25 mmol/L (HG) of glucose for 24 h. During 
the last 30 min, HUVECs were treated with different physiological concentrations of insulin, and whole cell lysates were prepared for Western Blot 
analysis. The panels show representative images of different independent experiments. Densitometric values were normalized to total amounts of 
ERK1/2, p38 and JNK, respectively. Bars represent mean ± SEM for five independent experiments. *P < 0.05, **P < 0.01 HG vs. NG
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phospho-eNOS is decreased after 24  h of high glucose 
and that physiological insulin treatment under this con-
dition cannot restore this activation.
PI3K and AKT are downstream effectors of insu-
lin signaling and are also involved in other pathways 
implicated in proliferation and survival [24], apoptosis, 
angiogenesis and cellular transformation [17]. In our 
study, we observe that, when HUVECs are exposed to 
24 h of high glucose, eNOS is not activated, while phos-
pho-AKT is increased. These results suggest that under 
high glucose conditions AKT is probably directed to 
positively regulate proliferation and endothelial cell 
survival.
Attenuated insulin signaling has been proposed as 
resulting from alterations in both the IR and post-
receptor signaling [25]. The IR is a heterodimeric pro-
tein complex, with an intracellular β-subunit (IRβ) and 
an extracellular α-subunit (IRα). Insulin binds to the IR 
through IRα, while the β subunit contains the intracellu-
lar tyrosin-kinase domain that initiates the signal cascade 
through the cytoplasm and the nucleus.
In the present study, we show that exposure to high 
glucose not only affects downstream IR signaling events, 
but also the total amount of intracellular β subunit. 
Under high glucose conditions, insulin is not able to 
phosphorylate the IRβ subunit, while it occurs under 
normal glucose conditions. Furthermore, IRβ total 
expression, which is decreased by high glucose, is unable 
to be restored through insulin treatment back to normal 
protein levels.
The decrease of IRβ total expression levels observed 
under high glucose potentiates the hypothesis that ele-
vated AKT phosphorylation in this condition has con-
sequences not only for eNOS activation, which directly 
depends on insulin signaling, but also for other effects 
governed by other pathways [17].
Conclusions
Our study suggests that insulin at physiological concen-
trations is not preventive but may even contribute to the 
vascular impairment of endothelial phenotype previously 
damaged by high glucose, due to an increased pro-ather-
ogenic pathway observed by an up-regulation of ERK1/2, 
p38 and JNK phosphorylation.
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Fig. 5 Administration of high glucose for 24 h attenuated IRβ total expression and its phosphorylated form in HUVECs. Physiological insulin 
increased IRβ tyrosine phosphorylation only for the condition of NG. Previously exposed to 24 h of 5 mmol/L (NG) or 25 mmol/L (HG) of glucose, 
cells were stimulated with different insulin concentrations for 30 min. Whole cell lysates were prepared for immunoblot analysis of the phosphoryl-
ated form of IRβ and the total amount of IRβ protein. The panels show representative images of different independent experiments. Densitometric 
values were normalized to total amounts of IRβ and actin, as indicated. Bars represent mean ± SEM for five independent experiments. *P < 0.05, 
**P < 0.01 HG vs. NG
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